Empagliflozin May be a Game Changer in Managing Pulmonary Embolism: A Case Report.
Mymensingh Med J
; 33(1): 311-312, 2024 Jan.
Article
de En
| MEDLINE
| ID: mdl-38163810
ABSTRACT
Pulmonary Embolism (PE) tolls heavy casualty on human lives because it is often misdiagnosed, and patients have limited access to quality care in resource constraint settings. It usually propagates from deep vein thrombosis of lower limbs. A Bangladeshi old lady suddenly developed symptoms on 19 March 2023. She had predisposing conditions like Type-2 Diabetes mellitus, hypertension and knee replacement surgery that made her bedridden for several years. Finding all the available parameters suggestive of PE, she received standard care but failed to have complete remission. When Empagliflozin was added to her treatment plan, she responded very well and got full recovery off her illness. This is the take away of the story.
Recherche sur Google
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Embolie pulmonaire
/
Thrombose veineuse
Type d'étude:
Diagnostic_studies
/
Etiology_studies
Limites:
Female
/
Humans
Langue:
En
Journal:
Mymensingh Med J
/
Mymensingh med. j
/
Mymensingh medical journal
Sujet du journal:
MEDICINA
Année:
2024
Type de document:
Article
Pays de publication:
Bangladesh